440 related articles for article (PubMed ID: 31195117)
1. Nicotinamide riboside, an NAD+ precursor, attenuates the development of liver fibrosis in a diet-induced mouse model of liver fibrosis.
Pham TX; Bae M; Kim MB; Lee Y; Hu S; Kang H; Park YK; Lee JY
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2451-2463. PubMed ID: 31195117
[TBL] [Abstract][Full Text] [Related]
2. Nicotinamide riboside supplementation exerts an anti-obesity effect and prevents inflammation and fibrosis in white adipose tissue of female diet-induced obesity mice.
Kim MB; Pham TX; vanLuling M; Kostour V; Kang H; Corvino O; Jang H; Odell W; Bae M; Park YK; Lee JY
J Nutr Biochem; 2022 Sep; 107():109058. PubMed ID: 35643283
[TBL] [Abstract][Full Text] [Related]
3. Hepatic steatosis induced by nicotine plus Coca-Cola™ is prevented by nicotinamide riboside (NR).
Rivera JC; Espinoza-Derout J; Hasan KM; Molina-Mancio J; Martínez J; Lao CJ; Lee ML; Lee DL; Wilson J; Sinha-Hikim AP; Friedman TC
Front Endocrinol (Lausanne); 2024; 15():1282231. PubMed ID: 38756999
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide riboside has minimal impact on energy metabolism in mouse models of mild obesity.
Cartwright DM; Oakey LA; Fletcher RS; Doig CL; Heising S; Larner DP; Nasteska D; Berry CE; Heaselgrave SR; Ludwig C; Hodson DJ; Lavery GG; Garten A
J Endocrinol; 2021 Sep; 251(1):111-123. PubMed ID: 34370682
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide riboside protects against liver fibrosis induced by CCl
Jiang R; Zhou Y; Wang S; Pang N; Huang Y; Ye M; Wan T; Qiu Y; Pei L; Jiang X; Huang Y; Yang H; Ling W; Li X; Zhang Z; Yang L
Life Sci; 2019 May; 225():20-28. PubMed ID: 30928408
[TBL] [Abstract][Full Text] [Related]
6. NAD
Li DJ; Sun SJ; Fu JT; Ouyang SX; Zhao QJ; Su L; Ji QX; Sun DY; Zhu JH; Zhang GY; Ma JW; Lan XT; Zhao Y; Tong J; Li GQ; Shen FM; Wang P
Theranostics; 2021; 11(9):4381-4402. PubMed ID: 33754067
[No Abstract] [Full Text] [Related]
7. Astaxanthin inhibits inflammation and fibrosis in the liver and adipose tissue of mouse models of diet-induced obesity and nonalcoholic steatohepatitis.
Kim B; Farruggia C; Ku CS; Pham TX; Yang Y; Bae M; Wegner CJ; Farrell NJ; Harness E; Park YK; Koo SI; Lee JY
J Nutr Biochem; 2017 May; 43():27-35. PubMed ID: 28193580
[TBL] [Abstract][Full Text] [Related]
8. Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice.
Gariani K; Menzies KJ; Ryu D; Wegner CJ; Wang X; Ropelle ER; Moullan N; Zhang H; Perino A; Lemos V; Kim B; Park YK; Piersigilli A; Pham TX; Yang Y; Ku CS; Koo SI; Fomitchova A; Cantó C; Schoonjans K; Sauve AA; Lee JY; Auwerx J
Hepatology; 2016 Apr; 63(4):1190-204. PubMed ID: 26404765
[TBL] [Abstract][Full Text] [Related]
9. The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.
Cantó C; Houtkooper RH; Pirinen E; Youn DY; Oosterveer MH; Cen Y; Fernandez-Marcos PJ; Yamamoto H; Andreux PA; Cettour-Rose P; Gademann K; Rinsch C; Schoonjans K; Sauve AA; Auwerx J
Cell Metab; 2012 Jun; 15(6):838-47. PubMed ID: 22682224
[TBL] [Abstract][Full Text] [Related]
10. Combined Treatment with L-Carnitine and Nicotinamide Riboside Improves Hepatic Metabolism and Attenuates Obesity and Liver Steatosis.
Salic K; Gart E; Seidel F; Verschuren L; Caspers M; van Duyvenvoorde W; Wong KE; Keijer J; Bobeldijk-Pastorova I; Wielinga PY; Kleemann R
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491949
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway.
Wang S; Wan T; Ye M; Qiu Y; Pei L; Jiang R; Pang N; Huang Y; Liang B; Ling W; Lin X; Zhang Z; Yang L
Redox Biol; 2018 Jul; 17():89-98. PubMed ID: 29679894
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide Riboside Supplementation to Suckling Male Mice Improves Lipid and Energy Metabolism in Skeletal Muscle and Liver in Adulthood.
Serrano A; Palou A; Bonet ML; Ribot J
Nutrients; 2022 May; 14(11):. PubMed ID: 35684059
[TBL] [Abstract][Full Text] [Related]
13. Nicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in Humans.
Nascimento EBM; Moonen MPB; Remie CME; Gariani K; Jörgensen JA; Schaart G; Hoeks J; Auwerx J; van Marken Lichtenbelt WD; Schrauwen P
J Clin Endocrinol Metab; 2021 Apr; 106(5):1437-1447. PubMed ID: 33524145
[TBL] [Abstract][Full Text] [Related]
14. High Dose of Dietary Nicotinamide Riboside Induces Glucose Intolerance and White Adipose Tissue Dysfunction in Mice Fed a Mildly Obesogenic Diet.
Shi W; Hegeman MA; Doncheva A; Bekkenkamp-Grovenstein M; de Boer VCJ; Keijer J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31614949
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide riboside supplementation alters body composition and skeletal muscle acetylcarnitine concentrations in healthy obese humans.
Remie CME; Roumans KHM; Moonen MPB; Connell NJ; Havekes B; Mevenkamp J; Lindeboom L; de Wit VHW; van de Weijer T; Aarts SABM; Lutgens E; Schomakers BV; Elfrink HL; Zapata-Pérez R; Houtkooper RH; Auwerx J; Hoeks J; Schrauwen-Hinderling VB; Phielix E; Schrauwen P
Am J Clin Nutr; 2020 Aug; 112(2):413-426. PubMed ID: 32320006
[TBL] [Abstract][Full Text] [Related]
16. Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model.
Joshi U; Evans JE; Pearson A; Saltiel N; Cseresznye A; Darcey T; Ojo J; Keegan AP; Oberlin S; Mouzon B; Paris D; Klimas N; Sullivan K; Mullan M; Crawford F; Abdullah L
Neurotoxicology; 2020 Jul; 79():84-94. PubMed ID: 32343995
[TBL] [Abstract][Full Text] [Related]
17. Fibronectin Type III Domain-Containing 5 Attenuates Liver Fibrosis Via Inhibition of Hepatic Stellate Cell Activation.
Zhou B; Ling L; Zhang F; Liu TY; Zhou H; Qi XH; Chen Q; Li YH; Kang YM; Zhu GQ
Cell Physiol Biochem; 2018; 48(1):227-236. PubMed ID: 30007970
[TBL] [Abstract][Full Text] [Related]
18. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed mice.
Moore MP; Cunningham RP; Davis RAH; Deemer SE; Roberts BM; Plaisance EP; Rector RS
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G564-G572. PubMed ID: 33501889
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide Protects Against Diet-Induced Body Weight Gain, Increases Energy Expenditure, and Induces White Adipose Tissue Beiging.
Méndez-Lara KA; Rodríguez-Millán E; Sebastián D; Blanco-Soto R; Camacho M; Nan MN; Diarte-Añazco EMG; Mato E; Lope-Piedrafita S; Roglans N; Laguna JC; Alonso N; Mauricio D; Zorzano A; Villarroya F; Villena JA; Blanco-Vaca F; Julve J
Mol Nutr Food Res; 2021 Jun; 65(11):e2100111. PubMed ID: 33870623
[TBL] [Abstract][Full Text] [Related]
20. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice.
Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G
J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
